Mainz Biomed B.V. (MYNZ)
NASDAQ: MYNZ · IEX Real-Time Price · USD
0.339
-0.006 (-1.80%)
At close: Jul 2, 2024, 4:00 PM
0.343
+0.004 (1.15%)
After-hours: Jul 2, 2024, 7:55 PM EDT
Mainz Biomed B.V. Market Cap
Mainz Biomed B.V. has a market cap or net worth of $7.42 million as of July 2, 2024. Its market cap has decreased by -89.22% in one year.
Market Cap
7.42M
Enterprise Value
6.74M
1-Year Change
-89.22%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed B.V.'s market cap has decreased from $58.55M to $7.42M, a decrease of -87.33%. That is a compound annual growth rate of -54.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 7.20M | -62.89% |
| Dec 29, 2023 | 19.40M | -81.13% |
| Dec 30, 2022 | 102.80M | -15.53% |
| Dec 31, 2021 | 121.70M | 107.86% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivos Therapeutics | 8.02M |
| Moleculin Biotech | 7.97M |
| Precipio | 7.91M |
| Molecular Templates | 7.77M |
| Sunshine Biopharma | 7.63M |
| Mangoceuticals | 7.55M |
| Cadrenal Therapeutics | 7.44M |
| Biomerica | 7.40M |